1. Development and validation of a HPLC–ES-MS/MS method for the determination of glucosamine in human synovial fluid
- Author
-
Pastorini, E., Rotini, R., Guardigli, M., Vecchiotti, S., Persiani, S., Trisolino, G., Antonioli, D., Rovati, L.C., and Roda, A.
- Subjects
- *
SYNOVIAL fluid , *HIGH performance liquid chromatography , *BODY fluid analysis , *GLUCOSAMINE , *DRUG analysis , *OSTEOARTHRITIS , *ORAL drug administration , *TANDEM mass spectrometry , *PATIENTS , *THERAPEUTICS - Abstract
Abstract: A new HPLC method for the determination of glucosamine (2-amino-2-deoxy-d-glucose) in human synovial fluid was developed and validated. Synovial fluid samples were analyzed after a simple protein precipitation step with trichloroacetic acid using a polymer-based amino column with a mobile phase composed of 10mM ammonium acetate (pH 7.5)–acetonitrile (20:80, v/v) at 0.3mL/min flow rate. d-[1-13C]glucosamine was used as internal standard. Selective detection was performed by tandem mass spectrometry with electrospray source, operating in positive ionization mode and in multiple reaction monitoring acquisition (m/z 180→72 and 181→73 for glucosamine and internal standard, respectively). The limit of quantification (injected volume=3μL) was 0.02ng, corresponding to 10ng/mL in synovial fluid. Calibration curves obtained using matrix-matched calibration standards and internal standard at 600ng/mL were linear up to 2000ng/mL. Precision values (%R.S.D.) were ≤14% in the entire analytical range. Accuracy (%bias) ranged from −11% to 10%. The recoveries measured at three concentration levels (50, 800, and 1500ng/mL) were higher than 89%. The method was successfully applied to measure endogenous glucosamine levels in synovial fluid samples collected from patients with knee osteoarthritis and glucosamine levels after oral administration of glucosamine sulfate (DONA®) at the dose of 1500mg/day for 14 consecutive days (steady-state). [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF